Personal information

Heart failure, Cardiac relaxation, Pharmacology, Induced Pluripotent Stem Cell, Genomics, Gene and cell therapy
France

Activities

Employment (3)

Université de Paris Faculté de Santé: Paris, Île-de-France, FR

2018-09-01 to present | Professor of Medicine (Pharmacology)
Employment
Source: Self-asserted source
Jean-Sébastien Hulot

Paris Cardiovascular Research Center: Paris, FR

2017-09 to present | Team Leader
Employment
Source: Self-asserted source
Jean-Sébastien Hulot

Université Pierre et Marie Curie - Faculté de Médecine: Paris, Île-de-France, FR

2013 to 2017 | Professor (Institute CardioMetabolism and Nutrition)
Employment
Source: Self-asserted source
Jean-Sébastien Hulot

Education and qualifications (2)

Université de Paris Faculté de Santé: Paris, Île-de-France, FR

2002-11-01 to 2005-12-05 | PhD
Education
Source: Self-asserted source
Jean-Sébastien Hulot

Université de Paris UFR de Médecine de Paris Centre: Paris, Île-de-France, FR

1997-11-01 to 2002-10-31 | MD
Education
Source: Self-asserted source
Jean-Sébastien Hulot

Professional activities (2)

European Society of Cardiology: Nice, FR

2019 to 2024 | Member (HFA - HFpEF Committee)
Service
Source: Self-asserted source
Jean-Sébastien Hulot

Société Française de Cardiologie: Paris, Île-de-France, FR

2020 to 2022 | President (GRRC)
Service
Source: Self-asserted source
Jean-Sébastien Hulot

Funding (7)

Mechanical Stretch Sensor Machinery and Relaxation of Human Cardiomyocytes

2022-10 to 2025-10 | Grant
Agence Nationale de la Recherche (Paris, FR)
Source: Self-asserted source
Jean-Sébastien Hulot

Endothelial dysfunction in heart failure with preserved ejection fraction

2020-03 to 2023-03 | Grant
Agence Nationale de la Recherche (Paris, FR)
Source: Self-asserted source
Jean-Sébastien Hulot

Patient-specific human induced pluripotent stem cells as a cellular platform to detect and predict anticancer drug-induced cardiac arrhythmias

2020 to 2023 | Grant
Fondation pour la Recherche Médicale (Paris, FR)
Source: Self-asserted source
Jean-Sébastien Hulot

Gene Editing Therapeutics for LMNA cardiomyopathy

2019-12 to 2023-12 | Grant
Agence Nationale de la Recherche (Paris, FR)
Source: Self-asserted source
Jean-Sébastien Hulot

Toward precision medicine with human iPS cells for cardiac channelopathies

2018-11 to 2024-12 | Grant
Fondation Leducq (Boston, FR)
Source: Self-asserted source
Jean-Sébastien Hulot

Communication between cardiomyocytes, cardiac stem cells and innate immune cells in failing hearts

2017 to 2020 | Grant
European Commission (PARIS, FR)
Source: Self-asserted source
Jean-Sébastien Hulot

Cellular and Molecular Targets to Promote Therapeutic Cardiac Regeneration

2013 to 2018 | Grant
Fondation Leducq (Paris, FR)
Source: Self-asserted source
Jean-Sébastien Hulot

Peer review (19 reviews for 10 publications/grants)

Review activity for Archives of cardiovascular diseases. (2)
Review activity for Cardiovascular research (1)
Review activity for European heart journal. (3)
Review activity for European journal of heart failure. (3)
Review activity for International journal of molecular sciences. (1)
Review activity for Journal of bioenergetics and biomembranes. (1)
Review activity for Journal of cardiovascular translational research. (1)
Review activity for Journal of internal medicine. (2)
Review activity for Journal of the American College of Cardiology (3)
Review activity for Stem cells translational medicine. (2)